vs
Side-by-side financial comparison of DIODES INC (DIOD) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $391.6M, roughly 1.3× DIODES INC). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.6%, a 4.2% gap on every dollar of revenue. On growth, DIODES INC posted the faster year-over-year revenue change (15.4% vs -1.7%). Over the past eight quarters, DIODES INC's revenue compounded faster (13.9% CAGR vs -0.1%).
Diodes Incorporated is a global semiconductor manufacturer that designs, produces and supplies discrete, analog and mixed-signal semiconductor products. Its solutions serve key end markets including automotive, industrial, consumer electronics, personal computing and communications infrastructure, with a worldwide customer base.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DIOD vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $391.6M | $493.8M |
| Net Profit | $10.2M | $33.7M |
| Gross Margin | 31.1% | — |
| Operating Margin | 3.4% | 9.9% |
| Net Margin | 2.6% | 6.8% |
| Revenue YoY | 15.4% | -1.7% |
| Net Profit YoY | 23.8% | 10.5% |
| EPS (diluted) | $0.23 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $391.6M | $493.8M | ||
| Q3 25 | $392.2M | $492.9M | ||
| Q2 25 | $366.2M | $468.8M | ||
| Q1 25 | $332.1M | $458.4M | ||
| Q4 24 | $339.3M | $502.4M | ||
| Q3 24 | $350.1M | $511.2M | ||
| Q2 24 | $319.8M | $504.3M | ||
| Q1 24 | $302.0M | $495.1M |
| Q4 25 | $10.2M | $33.7M | ||
| Q3 25 | $14.3M | $71.7M | ||
| Q2 25 | $46.1M | $39.3M | ||
| Q1 25 | $-4.4M | $20.7M | ||
| Q4 24 | $8.2M | $30.5M | ||
| Q3 24 | $13.7M | $19.4M | ||
| Q2 24 | $8.0M | $-153.0M | ||
| Q1 24 | $14.0M | $4.0M |
| Q4 25 | 31.1% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 31.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 33.7% | — | ||
| Q2 24 | 33.6% | — | ||
| Q1 24 | 33.0% | — |
| Q4 25 | 3.4% | 9.9% | ||
| Q3 25 | 3.0% | 13.8% | ||
| Q2 25 | 2.6% | 12.8% | ||
| Q1 25 | 0.4% | 7.0% | ||
| Q4 24 | 3.5% | 7.8% | ||
| Q3 24 | 6.2% | 6.6% | ||
| Q2 24 | 1.2% | -31.3% | ||
| Q1 24 | 4.3% | 3.2% |
| Q4 25 | 2.6% | 6.8% | ||
| Q3 25 | 3.6% | 14.5% | ||
| Q2 25 | 12.6% | 8.4% | ||
| Q1 25 | -1.3% | 4.5% | ||
| Q4 24 | 2.4% | 6.1% | ||
| Q3 24 | 3.9% | 3.8% | ||
| Q2 24 | 2.5% | -30.3% | ||
| Q1 24 | 4.6% | 0.8% |
| Q4 25 | $0.23 | $0.40 | ||
| Q3 25 | $0.31 | $0.84 | ||
| Q2 25 | $0.99 | $0.46 | ||
| Q1 25 | $-0.10 | $0.24 | ||
| Q4 24 | $0.18 | $0.37 | ||
| Q3 24 | $0.30 | $0.23 | ||
| Q2 24 | $0.17 | $-1.84 | ||
| Q1 24 | $0.30 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $377.0M | $375.2M |
| Total DebtLower is stronger | $25.7M | $570.5M |
| Stockholders' EquityBook value | $1.9B | $865.9M |
| Total Assets | $2.4B | $2.2B |
| Debt / EquityLower = less leverage | 0.01× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $377.0M | $375.2M | ||
| Q3 25 | $386.4M | $340.1M | ||
| Q2 25 | $327.3M | $224.7M | ||
| Q1 25 | $343.9M | $99.0M | ||
| Q4 24 | $316.1M | $229.9M | ||
| Q3 24 | $319.3M | $103.8M | ||
| Q2 24 | $273.9M | $19.4M | ||
| Q1 24 | $276.0M | $8.0M |
| Q4 25 | $25.7M | $570.5M | ||
| Q3 25 | $24.9M | $577.2M | ||
| Q2 25 | $26.4M | $583.9M | ||
| Q1 25 | $20.5M | $590.5M | ||
| Q4 24 | $20.7M | $597.1M | ||
| Q3 24 | $22.2M | — | ||
| Q2 24 | $20.3M | — | ||
| Q1 24 | $20.9M | — |
| Q4 25 | $1.9B | $865.9M | ||
| Q3 25 | $1.9B | $890.7M | ||
| Q2 25 | $1.9B | $833.8M | ||
| Q1 25 | $1.8B | $789.2M | ||
| Q4 24 | $1.8B | $764.9M | ||
| Q3 24 | $1.8B | $732.5M | ||
| Q2 24 | $1.8B | $706.5M | ||
| Q1 24 | $1.7B | $856.2M |
| Q4 25 | $2.4B | $2.2B | ||
| Q3 25 | $2.5B | $2.2B | ||
| Q2 25 | $2.5B | $2.1B | ||
| Q1 25 | $2.4B | $2.0B | ||
| Q4 24 | $2.4B | $2.2B | ||
| Q3 24 | $2.4B | $2.1B | ||
| Q2 24 | $2.4B | $2.0B | ||
| Q1 24 | $2.4B | $2.2B |
| Q4 25 | 0.01× | 0.66× | ||
| Q3 25 | 0.01× | 0.65× | ||
| Q2 25 | 0.01× | 0.70× | ||
| Q1 25 | 0.01× | 0.75× | ||
| Q4 24 | 0.01× | 0.78× | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.1M | $114.1M |
| Free Cash FlowOCF − Capex | $12.4M | — |
| FCF MarginFCF / Revenue | 3.2% | — |
| Capex IntensityCapex / Revenue | 6.6% | — |
| Cash ConversionOCF / Net Profit | 3.74× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $137.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.1M | $114.1M | ||
| Q3 25 | $79.1M | $137.3M | ||
| Q2 25 | $41.5M | $137.2M | ||
| Q1 25 | $56.7M | $-117.5M | ||
| Q4 24 | $81.8M | $133.0M | ||
| Q3 24 | $54.4M | $91.8M | ||
| Q2 24 | $14.4M | $107.0M | ||
| Q1 24 | $-31.1M | $-125.2M |
| Q4 25 | $12.4M | — | ||
| Q3 25 | $62.8M | — | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | $62.1M | — | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $-51.5M | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 12.3% | — | ||
| Q4 24 | 18.3% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | -1.1% | — | ||
| Q1 24 | -17.1% | — |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 5.6% | — | ||
| Q1 24 | 6.7% | — |
| Q4 25 | 3.74× | 3.39× | ||
| Q3 25 | 5.54× | 1.91× | ||
| Q2 25 | 0.90× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | 9.93× | 4.36× | ||
| Q3 24 | 3.95× | 4.72× | ||
| Q2 24 | 1.80× | — | ||
| Q1 24 | -2.22× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
